Monday, March 06, 2017 11:04:05 AM
AVII77,
Thank you for the clarification. Your explanation of the placement of that first red dot is what I understood you to mean except that I was also trying to get clarification about why you believe PFS would be low to begin with. This is why I interjected what I believed to be your past point about early apparent eventing being called progression due to potential faulty adjudication of pseudo progression. While pseudos should be balanced out, the potential for PFS benefit is lost and this might then drop that red dot into the zone you placed it in. I hope this makes sense. I would like your explanation of why you think the red dot might be where you placed it if not because of pseudoprogression events being called progression especially in light of potential OS benefit from DCVax. Best wishes.
Thank you for the clarification. Your explanation of the placement of that first red dot is what I understood you to mean except that I was also trying to get clarification about why you believe PFS would be low to begin with. This is why I interjected what I believed to be your past point about early apparent eventing being called progression due to potential faulty adjudication of pseudo progression. While pseudos should be balanced out, the potential for PFS benefit is lost and this might then drop that red dot into the zone you placed it in. I hope this makes sense. I would like your explanation of why you think the red dot might be where you placed it if not because of pseudoprogression events being called progression especially in light of potential OS benefit from DCVax. Best wishes.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
